BackgroundCheck.run
Search For

Marsha L Roach, 7337 Hamre Ln, Branford, CT 06405

Marsha Roach Phones & Addresses

37 Hamre Ln, Branford, CT 06405    203-4810392   

Groton, CT   

722 Vauxhall Street Ext, Waterford, CT 06385    860-4378396    860-4446280   

East Providence, RI   

New London, CT   

Rockville, MD   

Mentions for Marsha L Roach

Marsha Roach resumes & CV records

Resumes

Marsha Roach Photo 32

Executive Vice President At Phoenixsongs Biologicals, Inc.

Position:
Executive Vice President at PhoenixSongs Biologicals, Inc.
Location:
Greater New York City Area
Industry:
Biotechnology
Work:
PhoenixSongs Biologicals, Inc. - Branford, CT since May 2012
Executive Vice President
GigaCyte, LLC Dec 2010 - May 2012
Executive Vice President Research and Development
Zenith Biotech, LLC May 2009 - Dec 2010
Vice President Research and Development
CellDesign, Inc. May 2008 - Jun 2009
Vice President Research
Cognate BioServices 2007 - 2008
Vice President Research
University of Connecticut 2005 - 2007
S-Research Specialist
Pfizer, Inc Jul 1993 - Jul 2007
Senior Scientist
Education:
University of Illinois at Urbana-Champaign 1988 - 1993
Master's of Science, Developmental Biology and Embryology
Interests:
Stem cell derived model systems Stem Cells Developmental Biology Liver Biology Neural Biology
Marsha Roach Photo 33

Marsha Roach

Location:
United States
Marsha Roach Photo 34

Marsha Roach

Location:
United States
Marsha Roach Photo 35

Marsha Roach

Publications & IP owners

Us Patents

Disruption Of The Redk Gene

US Patent:
2003018, Oct 2, 2003
Filed:
Mar 28, 2003
Appl. No.:
10/402490
Inventors:
William Brissette - Stonington CT, US
John Hambor - Madison CT, US
Kuldeep Neote - East Lyme CT, US
Marsha Roach - Waterford CT, US
Assignee:
Pfizer Inc.
International Classification:
A01K067/027
C12Q001/68
C12N005/08
C12N005/06
US Classification:
800/003000, 800/018000, 435/006000, 435/354000, 435/372000
Abstract:
The invention features non-human mammals and animal cells that contain a targeted disruption of a REDK gene.

Growth And Differentiation Of Stem Cells

US Patent:
2004019, Sep 30, 2004
Filed:
Mar 30, 2004
Appl. No.:
10/813805
Inventors:
John Hambor - Madison CT, US
Marsha Roach - Waterford CT, US
Assignee:
Pfizer Inc
International Classification:
C12N005/08
US Classification:
435/370000
Abstract:
The present invention relates to methods of culturing stem cells to produce hepatocyte-like cells. Among other advances, the invention also relates to purified preparations of hepatocyte-like cells and methods for using the hepatocyte-like cells.

Disruption Of The Prostaglandin E Synthase 2 Gene

US Patent:
2003010, Jun 5, 2003
Filed:
Nov 13, 2002
Appl. No.:
10/293172
Inventors:
Laurent Audoly - Groton CT, US
Omar Francone - East Lyme CT, US
Mehrdad Haghpassand - North Stonington CT, US
John Hambor - Madison CT, US
Marsha Roach - Waterford CT, US
Jeffrey Stock - North Stonington CT, US
Assignee:
Pfizer Inc.
International Classification:
A01K067/027
C12N005/06
US Classification:
800/018000, 435/354000
Abstract:
The present invention features genetically-modified non-human mammals and animal cells containing a disrupted prostaglandin E synthase 2 gene as well as methods of treating an inflammation-mediated disorder involving administering an agent that inhibits prostaglandin E synthase 2.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.